NCT01408550View on ClinicalTrials.gov

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Bullous Pemphigoid
Interventions
DRUG

NPB-01

Intravenous immunoglobulin

DRUG

Placebo

Physiological saline

Trial Locations (1)

Unknown

Osaka

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY

NCT01408550 - Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids | Biotech Hunter | Biotech Hunter